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 Historically the source for most organ donations were from the cadavers of deceased 
donors. Over time living organ donation has become an important way to address the shortage of 
organ availability. The purpose of this literature review is to explore the psychosocial effect the 
organ donation process has on the living donor. The body’s physiological response to organ 
donation had been well documented. However, the psychosocial effect of donation is now being 
more appreciated and studies are being done to try to elucidate the factors that can influence the 
living donor’s response to the transplant pro The ultimate goal of these queries is to provide 
areas where clinicians can develop interventions that will enhance the post-donation experience 
for the living donor. To conduct this literature review peer-reviewed, English language research 
articles that were published between 2008 to the present were critiqued. In the end most living 
donors had a positive experience and would not hesitate to donate their organ again; however, 
there were a small minority of patients that did not fare well by psychosocial measures. These 
patients many times were aware that the graft had failed in the recipient. This was the single 
biggest factor in determining if the experience was positive or negative for the living donor. 
Strategies, such as internet-based cognitive behavioral intervention, are being to be developed to 
address the negative psychosocial outcomes that some living donors experience. Further studies 
are necessary to determine additional factors that may alter the living donor’s experience and to 
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 In the United States (US), 34,770 solid organ transplants were performed in 2017 (U.S. 
Department of Health and Human Services, 2018). The number of solid organ transplants 
performed in the US increases each year causing an ever-growing number of people with end-
stage organ failure to be placed on waiting lists until a matched donor organ is available.  As of 
2018, there were 114,000 people awaiting a solid organ transplant (U.S. Department of Health 
and Human Services, 2018). Renal transplants comprise approximately 56% of the solid organ 
transplants performed in the US in 2017 while liver transplants account for approximately 23% 
of the solid organ transplants during that year (U.S. Department of Health and Human Services, 
2018). Regretfully, many individuals with end-stage organ failure placed on waiting lists for 
solid organ transplant will not receive a transplant in time. As many as 20 people die each day in 
the US waiting for a compatible organ for transplant (U.S. Department of Health and Human 
Services, 2018). Unlike other solid organ transplants, organs for kidney and liver transplant can 
come from healthy living donors as well as recently deceased donors. In the case of liver and 
kidney transplantation, organs volunteered from living donors can greatly expand the availability 
of viable organs for transplant. In some instances, complications and side effects related to organ 
donation can arise that adversely affect the donor. In the proceeding fifty years much of the focus 
has been placed on long-term complications the recipient of an organ endures. However, there is 
a paucity of research that explores the long-term consequences of organ donation experienced by 
the living transplant donor. 
 There are several unique burdens a person donating an organ can experience during the 
years following surgical excision of a healthy organ. Organ donors may potentially have to take 
leave from work due to unforeseen complications arising from donation, and the donor can then 
2 
 
have problems paying their monthly bills. In addition, donors may be denied health insurance 
and life insurance following donation, which causes long-term financial difficulties. Besides the 
financial burden that donors may incur due to time off work and future insurability issues, donors 
may experience emotional, substance abuse, or other negative psychosocial burdens. While most 
living organ donors do not experience any ill effects from donating their organs, up to 10% of 
living kidney donors experience negative psychosocial outcomes (Jacobs, Gross, Messersmith, 
Hong, Gillespie, Hill-Callahan, Taler, Jowsey, Beebe, Matas, Odim, & Ibrahim, 2015). Some 
indicators such as underlying psychological distress and substance abuse problems are known 
before undergoing donation and can increase the likelihood of the donor experiencing negative 
psychosocial outcomes. On the other hand, lack of support and graft failure are important 
indicators that can lead to negative psychosocial outcomes but are not apparent until after the 
procedure. Jacobs and colleagues reported that up to 38% of kidney donors feel that they do not 
receive support even from hospital staff following organ donation (Jacobs, et al., 2015). 
However, graft failure was the greatest predictor of negative psychosocial outcome in post-
transplant donors (Jacobs, et al., 2015). Despite recognition that the negative psychosocial 
outcomes can be problematic for a subset of organ donors, little has been proposed in the way of 










 Living donor organ transplantation provides organs to individuals with organ failure that 
would otherwise remain on waiting lists due to the lack of availability of solid organs suitable for 
transplantation. However, since the inception of living organ donor transplantation, little 
attention has been paid to the long-term consequences the organ donor has to endure following 
the procedure.  Evaluation of transplanted organs has mainly focused on the physiologic and 
psychologic long-term outcomes in organ recipients, although more recently, problems 
experienced by living organ donors is gaining attention.  
 The negative financial and psychosocial effects organ donation has on the living donor 
has become more apparent. The single biggest predictor of the donor experiencing a negative 
psychosocial outcome is related to whether the graft fails after being implanted into the recipient. 
Identifying interventions aimed at alleviating the negative psychosocial effects of transplantation 
for donors would be beneficial in improving outcomes. Given that donors whose recipients had a 
graft failure are at the highest risk of developing negative psychosocial consequences, 
identifying the subset of living organ donors with recipients that have grafts failure or rejection 











 The purpose of this literature review is to analyze the negative psychosocial effects that 
organ donors experience after donation and to understand which donors are most at risk for 
suffering negative experiences related to organ donation. It has been suggested that living kidney 
donors experience mood disorders, fear of future organ failure, body image issues, and life 
dissatisfaction more frequently than healthy controls (Rodrigue, Schold, Morrissey, Whiting, 
Vella, Kayler, Katz, Jones, Kaplan, Fleishman, Pavlakis, & Mandelbrot, 2017). Exploring 
effective interventions aimed at identifying possible complications of organ donation pre- and 
post-transplant in the recipient and in the living donor could be useful in ensuring the best 
possible psychologic and physiologic outcomes are experienced by the living donor. 
 The United Network for Organ Sharing (UNOS) has identified areas that can be assessed 
as part of a psychosocial evaluation prior to donation. The areas identified by UNOS include 
motivation to donate, social support, health behaviors, psychosocial history, psychiatric history, 
donor knowledge and understanding of the risks, and family history as wells as financial history 
and legal preparedness (Rudow, Swartz, Phillips, Hollenberger, Schmick, & Steel, 2015). 
Another pre-donation screening tool developed is the Ethical, Legal, and Psychosocial Aspects 
of Organ Transplantation (EPAT) (Massey, Timmerman, Ismail, Duerinckx, Lopes, Maple, 
Mega, Papachristou, & Dobbels, 2017). Screening tools can assist the transplant team in the 
identification of living donors at risk for poor psychosocial and physiologic outcomes after 
donation and can raise awareness of the implications organ donation has on donor health status.   
 Understanding the effects of organ donation on the living donor will aid in caring for 
donors post-transplant. Many individuals donating an organ will have positive experiences 
before and after donation; however, organ donation has both physiologic and psychosocial 
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effects that can vary between individual experiences.  Interventions can be developed to prevent 
or lessen the impact of the physiologic and psychosocial effects on the donor. The information 
synthesized from this literature review is expected to address physiologic and psychosocial 
experiences of living organ donors and to explore interventions aimed at reducing the negative 






















 A review of the literature will be conducted to examine the physiologic and psychosocial 
effects of organ transplantation on living donors from the following online databases: 
Cumulative Index to Nursing and Allied Health Literature (CINAHL), Medical Literature On-
Line (MEDLINE), Educational Resource Information Center (ERIC), and Psychological 
Information database (PsycINFO) (Appendix A, Figure 1). Searches used a combination of the 
following terms: ‘organ transplant*’, ‘living donor*’, ‘physiologic*’, and ‘psychosocial*’. 
Articles included in the review will be published from 2008-2019, in the English language from 
peer-reviewed journals. Articles will be reviewed to ensure relevance to the topic.  Inclusion 
criteria will consist of 1) focus on physiologic and psychosocial health status of living donor pre- 
and post-donation, 2) experience of donation from the donor’s perspective, and 3) interventions 
aimed at minimizing negative experiences from the donor’s point of view. Articles that focus on 
the recipient experience in living donor organ transplantation will be excluded.  
 No relevant articles were identified when all four search terms were used. When, 
physiologic* was excluded from the search, 258 articles were found (Appendix A, Figure 1). 57 
articles were evaluated and individually critiqued. Only one article met the inclusion criteria by 
specifically addressing both the psychosocial and physiological effects of organ donation. 
Another 17 articles were identified that pertained to the psychosocial effects of organ donation 
on the living donor. Three articles were identified that were outside the date range of the search 








 Organ systems in the human body have specialized tasks to perform functions that 
maintain homeostasis. In certain disease conditions, pathological changes can occur in the body’s 
organs and impair their ability to properly function. Overtime pathological changes can cause the 
organ to become permanently damaged, losing the ability to function and perform its 
physiological role. When this happens, it is difficult for the body to compensate for the loss of 
the organ due to tissue specialization innate to each organ and the biologic inability to regrow a 
new organ. Ultimately the failure of an organ can lead to death. Solid organ transplantation is a 
procedure that is performed when one or more organs have failed in attempt to restore organ 
function. The procedure requires an intricate process that involves the screening patients and 
donors, procurement of an organ, transporting the organ between institutions, and the 
implantation into the patient with the failing organ. When the first kidney transplant was 
performed in 1954 between two living identical twins, death would have been a common 
sequelae from organ failure (Keller, 2015). Over the 6 decades since solid organ transplantation 
has been performed great advances have been made in the types of organs that can be 
transplanted and the survivability of the procedure. Kidney, liver, heart, and lung transplantation 
are some of the most common solid organ transplants performed today (Keller, 2015). 
Postsurgical management following transplantation has been an important advancement that has 
enabled transplanted organs to function for extended periods of time. Early on survival rates 
were low, but the introduction of immunosuppressant therapy opened the door to improved 
treatment for organ transplant patients.  
Living Organ Donation 
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 Historically, transplanted organs were obtained from a deceased donor. Due to the nature 
of procuring organs from deceased donors, the need for organs greatly outpaced the availability 
of the organs. Most patients who received organ transplants obtained their organs from deceased 
donors. Lack of donations and the fact that all organs from deceased donors are not useable in 
transplantation greatly reduces the number of patients who can receive a new organ. While a 
majority of the organs utilized in transplantation still come from deceased donors, approximately 
4 out of 10 are obtained from live donors (U.S. Department of Health and Human Services, 
2018). Being able to remove a whole or part of an organ from a living donor and then implanting 
it into a recipient has greatly expanded the number of organs, such as the kidney or liver, that are 
available for transplantation. However, the ability to remove an organ or a part of one from a 
living donor and transfer the organ to a recipient presents a unique set of ethical and medical 
issues for all involved. 
Medical Management 
 Advancements in post-surgical management of transplant recipients has increased their 
survival rate. Immunosuppressant therapy has assisted in reducing the incidence of organ 
rejection in transplant recipients. Cyclosporine, which was first used in the early 1980’s, was a 
mammoth advance that helps prevent the recipient from rejecting the donor organ (Keller, 2015). 
Another important area in the management of individuals with transplanted organs has been in 
preventing infections due to immunosuppression. However, much less research has been done to 
characterize the long-term effects of organ transplantation on the living donor. While living 
donors do not have to worry about rejecting their remaining organ or infections like recipients, 
other complications often arise that can greatly affect the living donor’s quality of life. It is 
possible for the donor’s remaining organ to fail, which would then necessitate them receiving an 
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organ transplant. Recognizing that organ donation is not a benign process and can have 
ramifications on the living donor’s life is an important advance in the transplant process. 
Psychosocial Effect in Transplantation 
 Historically much of the attention has focused on the effects that organ transplantation 
has on the recipient. Besides having to consider organ rejection in recipients post-transplant, 
recipients are also at risk for developing negative psychosocial outcomes following the 
procedure. Depression, anxiety, aggression, and hopelessness are a few of the reported negative 
psychosocial changes that have been reported in people with chronic illnesses (Schulz & 
Kroencke, 2015). Addressing psychosocial issues has long-term implications for the health of the 
transplant recipient. For example, depression in a transplant recipient can lead to lack of 
compliance with their immunosuppressant regimen and a decrease in their quality of life 
(Heinrich & Marcangelo, 2009). This is important because without adhering to the 
immunosuppressant regimen, the recipient could possible suffer organ rejection. After 
undergoing surgical implant of a donor organ, the potential for adverse psychosocial effects is 
greatest the first year after transplant. There are also financial pressures on living organ donors, 
just as there are for people with chronic illnesses, due to missing work following the procedure 
and due to the recovery period. One psychosocial dimension that is different for living organ 
donors pertains to whether the transplantation was successful or not. Graft success or failure is an 
important predictor of psychosocial outcomes experienced by the living organ donor with graft 
failure leading to potentially negative outcomes. 
 In the current body of literature, the effects of organ transplantation in living 
organ donors is not as well delineated. In living tissue donation, kidneys are the most common 
organ that is harvested and transplanted. The transplantation of livers from living donors is less 
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common but still represents a significant number of procedures. Recently, the risks posed by 
donating organs has been a focus of concern.  Beyond having a potential effect on the donor’s 
health, other factors precipitated by organ donation can affect the donor’s quality of life. The 
adverse effects that occur to organ donors can determine how they perceive the procedure. Most 
donors donate their organs willingly to benefit those in need. This altruistic act normally has a 
beneficial psychological effect on the donor. However, a minority of organ living organ donors 
have a negative outcome from the donation process and this can greatly affect the donor’s 
perception of the procedure. When the living donor experiences either a negative health or 
psychosocial outcome, the living donor is more likely to regret the decision to donate their organ 
in the first place. Understanding which living donors are at risk for developing adverse effects 
from donating may allow health care providers to intervene, which will ultimately make for a 
more positive experience for the living organ donor. 
Organ donation can have multifactorial effects on the living donor’s health status, as well 
as on the individual’s mental health well-being. In the case of kidney transplantation, the living 
donor undergoes surgical resection and harvest of a healthy kidney to a recipient. The living 
donor can successfully maintain physiologic homeostasis with one functional kidney, which is 
why the procedure is feasible. To compensate the remaining kidney might hypertrophy. The 
increase in size is indicative of the increased functional role even though the total capacity has 
been reduced by removal of one of the organs. Once the living donor has donated their kidney, 
the donor is at risk if their remaining kidney were to fail. The living donor in this situation would 
require a kidney transplant. Even if the living donor’s remaining kidney does not completely fail, 
it is possible that their kidney function may still decline. Meyer and colleagues reported that 26.7 
percent of the living kidney donors had a low estimated glomerular filtration rate (eGFR) 
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(Meyer, Hartmann, Mjøen, & Andersen, 2017). A living donor was defined as having a low 
eGFR if it was less than 60 mL/min/1.73 m2. In addition, Meyer and colleagues reported that 
33.2 percent of the living donors in the cohort reported having hypertension following organ 
donation (Meyer, et al., 2017). In the study hypertension was defined as having a blood pressure 
greater than 140/90. One of the kidney’s functions is in regulating blood pressure. The alterations 
caused by donating a kidney might explain why living donors experience an increase in blood 
pressure.      
The psychosocial effects of transplantation on the living donor are less understood. Since 
only a minority of living donors experience a negative psychosocial outcome, it is imperative to 
understand which donors are more likely to experience the complications. Factors such as age, 
relationship status, social support, financial status, and coping style have been looked at in 
relation to the development of negative psychosocial outcomes in living donors. Age has been 
identified as a predictor of negative psychosocial wellbeing after organ donation in living donors. 
Younger kidney donors who were not married are more likely to exhibit negative psychosocial 
effects post-donation. The same trend has been observed in living liver donors. Being 40 to 50 
years old was associated with a more positive effect on the donation experience (Dew, 
DiMartini, Ladner, Simpson, Pomfret, Gillespie, Merion, Zee, Smith, Holtzman, Sherker, 
Weinrieb, Fisher, Emond, Friese, Burton, & Butt, 2016). Also, the financial burden resulting 
from organ donation can be substantial. The living donor may miss work, which can lead to a 
decrease in wages. In addition, the recovery period can sometimes be longer than expected. The 
longer it takes to recover can strain finances. Another financial hardship can be placed on the 
donor due to the inability to get health and life insurance years after the donation. Financial and 
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social support can affect the level of stress the living organ donor experiences. The living 
donor’s ability to cope with these stresses will affect their perception of the donation process. 
Further, living organ donors have many of the same psychosocial changes experienced in 
the organ donor recipients. Living organ donors can have depression and anxiety due to changes 
in their health status and fear regarding what happens if their remaining organ fails. Living organ 
donor may be frustrated due to the perception that once they have donated their organ they are an 
afterthought and do not receive as much follow-up by the healthcare team following the 
procedure. There are also financial pressures on living organ donors, just as there are for people 
with chronic illnesses, due to missing work following the procedure and due to the recovery 
period. One psychosocial dimension that is different for living organ donors pertains to whether 
the transplantation was successful or not. Graft success or failure is an important predictor of 
psychosocial outcomes experienced by the living organ donor with graft failure leading to 
potentially negative outcomes. 
 Graft failure in organ transplantation has serious implications for the recipient’s ability to 
survive short of receiving another organ donation. While this is imminently more stressful for the 
organ recipient due to the life and death issues presented by the situation, it is also 
understandable that the person who just donated an organ could also be affected by this adverse 
outcome. Graft failure has been shown to be one of the few causes for living donors to have 
regrets in undergoing the organ transplantation process (Meyer, Wahl, BjØrk, WislØff, Harmann, 
& Andersen, 2016). There are many reasons why graft rejection could lead to regrets the donor 
experiences. The donor could resent the time and financial burden that they went through if the 
graft rejects. Graft failure could be particularly difficult for the living donor if the recipient was a 
close relative. The donor could experience a feeling of guilt due to the fact that the recipient did 
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not survive. Understanding the guilt that living organ donors experience and developing nursing 
interventions to alleviate this negative psychosocial effect will be invaluable for improving the 
donor’s experience following the transplantation procedure. 
Education 
 Interventions used to lessen the impact of transplant complications affecting the living 
donor would be useful to alleviate negative psychosocial effects of the transplant process on the 
living donor. Psychosocial causes of distress that effect the living donor can be difficult to target. 
Some examples have been suggested in the literature for interventions to prevent poor 
psychosocial outcomes. One example is of an internet-based cognitive-behavioral intervention 
(ICBT). In this pilot study the health-related quality of life, anxiety, and depression were 
observed before and after the intervention to see if the ICBT was effective at alleviating 
problems associated with organ donation (Wirken, van Middendorp, Hooghof, Bremer, Hopman, 
van der Pant, Hoitsma, Hillbrands, & Evers, 2018). The ICBT had extensive donation-related 
treatment modules, assignments, and psychoeducation. In the pilot study, most participants 
reported benefits on health and psychological health-related quality of life measures, depression 
measures, and in reports of fatigue. Further studies are warranted because the scores are based 
off the responses of eight living donors. This provides a starting point to develop this and other 
methods to prevent living donors from developing negative psychosocial outcomes that 








 Twenty-one studies were identified related to the psychosocial effect organ donation has 
on the living organ donor. The studies were included in the literature review. Included in the 
articles were two sentinel studies, one of which was a pilot study in the discipline, from 2001 and 
2002. Twenty studies had been published since 2008. All the studies were cohort studies. All the 
studies used various questionnaires to measure the living donors’ quality of life. Five of the 
studies involved qualitative interviews of the living donors following the transplant procedure. 
Psychosocial Outcomes in Living Donors Post-Donation 
 The literature review identified two major groups of living organ donors. The majority of 
living organ donation involves transplantation of the kidney; however, there are a significant 
number of liver transplants involving living organ donors. The studies synthesized in the 
literature search identified certain factors that can negatively affect the psychosocial outcomes 
kidney and liver donors experience.  
Psychosocial Outcomes in Living Kidney Donors 
 Ten studies were identified that explored the psychosocial effect of organ donation in 
living kidney donors. 
 The health-related quality of life (HRQoL) questionnaire was examined in living kidney 
donors (LKD) for a small cohort study, which involved the donors responding to the Short Form-
36 (SF-36), Giessen Subjective Complaint List (GBB-24), and the Zerssen’s Mood Scale (Bf-S) 
questionnaires (Maglakelidze, Pantsulaia, Managadze, & Chkhotua, 2011). In the eight domains 
of the SF-36, social function (p=0.0001), bodily pain (p=0.0357), and vitality (p=0.0478) were 
domains the living kidney donors scored higher and more positive ratings than the control 
patients or renal tumor patients who had undergone nephrectomies (Maglakelidze et al., 2011). 
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In addition, the living kidney donors (LKD) scored higher in the GBB-24, and the only domain 
in which the difference in scores was statistically significant was in the gastric complaints 
domain (p=0.008) (Maglakelidze et al., 2011). In the Bf-S questionnaire, the living donors scored 
higher than both the control and renal tumor patients (p=0.0007 versus controls and p < 0.0001 
versus patients) (Maglakelidze et al., 2011). This study indicated that LKDs fared well following 
organ donation by the measures of HRQoL included in the study. 
 Another study explored the effect organ donation had on psychosocial outcomes in 
LKDs. In the study, various questionnaires were employed to measure the effect organ donation 
had on the LKDs psychosocial outcomes (Maple, Chilcot, Weinman, & Mamode, 2017). The 
Short Form-12 (SF-12) was utilized to measure the LKDs physical HRQoL (Maple et al., 2017). 
The LKDs were found to have a significantly lower SF-12 score 3 months following donation (p 
< 0.05); however, the SF-12 score at 12 months following donation was lower than the pre-
donation score but not significantly lower (Maple et al., 2017). This study also found that by all 
measures LKDs had very little change in their HRQoL by 12 months after kidney donation.  
 In another cohort study, the investigators were interested in determining the long-term 
effects on mood in organ donors following kidney donation. The investigators utilized the Patient 
Health Questionnaire (PHQ-9) depression screening instrument, the Life Orientation Test-
Revised, and the 36-Item Short Form Health Survey to screen LKDs following donation 
(Jowsey, Jacobs, Gross, Hong, Messersmith, Gillespie, Beebe, Kew, Matas, Yusen, Hill-
Callahan, Odim, Taler, & the RELIVE Study Group, 2014). The study found the biggest 
predictors of the living organ donor suffering from symptoms of depression following kidney 
donation consisted of being a race other than white (p=0.020), being younger when they donated 
their kidney (p=0.002), having a longer recovery time following donation (p=0.0009), having a 
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large financial burden (p=0.013), and feeling obligated to donate the kidney (p=0.003) (Jowsey 
et al., 2014). The study identified factors that could indicate the living donor was more likely to 
develop depression following organ donation even though the overall prevalence of depression 
was similar between LKD and the controls. 
 Other psychosocial outcomes evaluated following organ donation included mood, body 
image, fear of kidney failure, and decisional stability. One study used the Profile of Mood States 
(POMS) to assess anxiety, depression, and mood, the 5-Item Fear of Kidney Failure 
questionnaire, 10-Item Body Image Scale (BIS), and 5-Item Satisfaction with Life Scale (SWLS) 
to measure the psychosocial outcomes in LKDs (Rodrigue et al., 2017). The outcomes measured 
in this study yielded similar results for LKDs and healthy controls (HC). When looking for 
predictors of psychosocial outcomes following donation, older age was associated with less 
chance of developing a mood disorder post-donation (p=0.001) and having a mood disorder pre-
donation was more likely to be associated with a mood disorder following donation (p=0.01) 
(Rodrigue et al., 2017). The predictors of fear of kidney failure were marital status with being 
married associated with less change of developing the fear (p=0.004) and pre-donation fear of 
kidney failure increasing the chances of developing the fear post-donation (p < 0.001) (Rodrigue 
et al., 2017). Pre-donation body image issues and feeling pressured to donate were predictors of 
having body image issues following donation (p=0.002 and p=0.02, respectively) (Rodrigue et 
al., 2017).  Being white was associated with a decreased chance of developing life dissatisfaction 
while pre-donation life dissatisfaction was associated with an increased chance of developing life 
dissatisfaction following donation (p=0.003 and p <0.001, respectively) (Rodrigue et al., 2017). 
While the LKDs and HCs had comparable psychosocial outcomes, several predictors of negative 
outcomes for LKDs were identified in this study. 
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 The factors that have negative and positive effects on LKDs along with the HRQoL were 
explored in a randomized, cohort study (Hsieh, Chien, Liu, Wang, Lin, & Chiang, 2017) 
following organ donation. In this study women demonstrated a higher positive psychosocial 
effect than men (p < 0.05) (Hsieh et al., 2017) following the donation and transplant experience. 
Also, lack of having a chronic disease was associated with having a positive effect on 
psychosocial perceptions of the donation experience (Hsieh et al., 2017). The psychosocial 
ratings were more favorable following organ donation if the person perceived themselves as 
having greater physical health prior to the organ donation (p < 0.01) (Hsieh et al., 2017). When 
the psychosocial effects of organ donation were rated as higher by the donor, the LKDs generally 
had higher HRQoL scores (p < 0.05) (Hsieh et al., 2017). This study indicated that LKDs rating 
their donation experience as positive with fewer negative effects had higher HRQoL scores.   
 To predict mental health following donation in LKDs, several psychological factors were 
explored to determine their effect on mental health. In one prospective cohort study 
(Timmerman, Timman, Laging, Zuidema, Beck, Ijzermans, Busschbach, Weimar, & Massey, 
2016), the authors reported that being young (p=0.002) and having a deficiency in social support 
indicated and increased risk for negative psychological symptoms (Timmerman et al., 2016). 
Also, increased amounts of stress led to a decrease in overall well-being (p < 0.001) 
(Timmerman et al., 2016). Providers that recognize potential predictors of negative psychosocial 
outcomes in LKD can improve the organ donation experience by optimizing interventions aimed 
at decreasing stress in the donor and by surrounding the donor with supportive individuals.  
 Previously, Timmerman, Laging, Westerhof, Timman, Zuidema, Beck, Ijzermans, Betjes, 
Busschbach, Weimar, & Massey (2015) suggested there was no difference between the mental 
health outcomes for LKDs and HCs. The authors reported no change in psychological complaints 
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(p=0.20) or in well-being (p=0.10) for LKDs following organ donation (Timmerman et al., 
2015). There was also no difference detected between the LKDs and HCs in regards to changes 
in psychological complaints and in well-being (p= 0.48 and p=0.85, respectively) (Timmerman 
et al., 2015). Ultimately this study suggests there are no discernible differences between LKDs 
and HCs in mental health outcomes.  
 Another group looked at the prevalence of anxiety, depression, and regret of donation in 
LKDs following donation. In this cohort study, the rates of anxiety, depression, and regret of 
donation in LKDs was 5.5%, 4.2%, and 2.1%, respectively (Holscher, Leanza, Thomas, 
Waldram, Haugen, Jackson, Bae, Massie, & Segev, 2018). The chances of a positive screening 
for depression were higher if the LKD screened positive for anxiety (p < 0.001) (Holscher et al., 
2018). There was also an increased chance of having a positive depression screen if the recipient 
of the kidney lost the graft (p < 0.001) (Holscher et al., 2018). The LKD was more likely to 
regret the decision to donate the kidney if the LKD had a positive anxiety screen (p < 0.0001) 
(Holscher et al., 2018). These factors were the only ones that were found in this study to be 
predictors associated with anxiety, depression, or regret of donation. 
 Meyer, Wahl, Bjørk, Wisløff, Hartmann, & Andersen (2016) reported on quality of life 
(QoL) measures eight to twelve years following the living donor’s kidney donation. Most of the 
donors had high QoL scores. The only significant findings were that women had higher fatigue 
score than men (Meyer et al., 2016). Women scored significantly higher than men in general 
fatigue (p=0.01), physical fatigue (p=0.01), reduced motivation (p=0.04), and mental fatigue 
(p=0.03) (Meyer et al., 2016). Gender may be a factor that clinicians may look at in LKDs to 
ensure that female donors are not adversely affected by fatigue following donation.  
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 Like other studies, graft failure was identified as a factor in poor psychological outcomes 
of LKDs (Jacobs, Gross, Messersmith, Hong, Gillespie, Hill-Callahan, Taler, Jowsey, Beebe, 
Matas, Odim, Ibrahim, & the RELIVE Study Group, 2015). The study suggested one in ten 
LKDs experienced a negative psychosocial or financial consequence following donation (Jacobs 
et al., 2015). The only predictor of a negative psychosocial outcome statistically significant was 
if the recipient’s kidney was no longer functioning (p < 0.001) (Jacobs et al., 2015). This is 
consistent with the findings of similar cohorts of living organ donors. Graft failure has been 
reported to have negative consequences on the LKDs psychosocial outcomes  (Holscher et al., 
2018). 
Psychosocial Outcomes in Living Liver Donors 
 Ten studies were identified that addressed the psychosocial outcomes in living liver 
donors (LLD). Three of the cohort studies did not meet the inclusion criteria because they were 
published before 2008, when there was a sharp increase and better outcomes in living organ 
donation due to advanced drug therapies and surgical techniques but were included to give 
context to the topic. 
 Walter, Bronner, Pascher, Steinmüller, Neuhaus, Klapp, & Danzer (2002) looked at the 
psychosocial outcomes of LLDs at six months following the transplant procedure. Overall the 
participants in the study had a higher global quality of life 6 months after the procedure 
(p=0.044) (Walter et al., 2002). However, 26% of the LLDs also had high values for tiredness (p 
< 0.0012) and fatigue (p < 0.0012). Ultimately most of the LLDs in the study had a good QoL 
following donation, and the procedure could be done without the ethical dilemma of doing harm 
to the donor. 
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 Another early article described the QoL of LLD before and after liver donation. The 
LLDs were assessed using the WHOQoL questionnaire (Walter, Dammann, Papachristou, 
Neuhaus, Danzer, & Klapp, 2003). Before donating the LLDs scored higher on the WHOQoL 
questionnaire than the general population (p < 0.05) (Walter eta l., 2003). At six months, the 
LLDs were re-assessed with the WHOQoL and the LLDs score significantly lower on physical 
health (p < 0.05) and living conditions (p < 0.05) than before they donated their livers (Walter et 
al., 2003). This study suggested the LLD’s, had a positive psychosocial outcome after partial 
organ donation following transplantation to the recipient. 
 In the final early cohort study, the authors looked at the QoL that LLDs experienced 
following transplant. The LLDs scored similar to HCs on the SF-36, which has been a validated 
questionnaire to assess QoL. The only domains that the LLDs differed from the HCs were 
physical function, social function, and mental health (p < 0.05) (Trotter, Talamantes, McClure, 
Wachs, Bak, Trouillot, Kugelmas, Everson, & Kam, 2001). Ultimately, the some LLDs reported 
body image issues, mild ongoing symptoms such as abdominal discomfort, significant out of 
pocket expenses; however, all the LLDs stated that they would donate a portion of their livers 
again if given the chance (Trotter et al., 2001). This was an early study that demonstrated the 
lack of harmful effect for people donating a section of their liver to another. 
 DuBay, Holtzman, Adcock, Abbey, Greenwood, Macleod, Kashfi, Jacob, Renner, Grant, 
Levy, & Therapondos (2009) looked at the QoL living donors experienced and looked at 
predictors to those outcomes. The physical composite score as measured by the responses of 
LLDs on the SF-36 demonstrated a higher physical composite score (p < 0.001) (DuBay et al., 
2009). Physical functioning (p < 0.001), role interference (p < 0.05), bodily pain (p < 0.001), 
general health (p < 0.001), and vitality (p < 0.05) were all domains that the LLDs scored better 
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than the average Canadian on (DuBay et al., 2009). While LLDs reported mental health scores 
on the SF-36 similar to the average Canadian, there were several predictors , such as age 
(p=0.023), presence of a psychiatric diagnosis (p=0.007), degree attained (p=0.001), and pre-
donation concerns about donation all (p=0.029) that were all predictors of mental health changes 
seen following liver donation (DuBay et al., 2009). This study identified some predictors that 
could cause changes in a LLDs mental health outcomes following organ donation. 
 In a multicenter cohort study, the authors identified several factors that affect the 
psychological outcomes in LLDs. Butt, Dew, Liu, Simpson, Smith, Zee, Gillespie, Abbey, 
Ladner, Weinrieb, Fisher, Hafliger, Terrault, Burton, Sherker, & DiMartini (2017) identified 
factors that affect the Simmons better person score were time since donation (p < 0.001), being a 
first degree relative versus unrelated (p=0.012), female gender (p=0.008), recipient death (p < 
0.001), ambivalence (p=0.005), and motivation to donate (p < 0.001) (Butt et al., 2017). The 
predictor that was more likely to be associated with a negative donation experience was the death 
of the recipient. Up to 22% of the LLDs felt responsible when the recipient died following the 
transplant (Butt et al., 2017). This study reiterated the fact that the recipient’s outcome can have 
a great effect on the donor’s experience. 
 A cohort study conducted in Japan, compared the psychological outcomes of recipient 
and donors three to five years following living donor liver transplants. In this study, the social 
QoL (p= 0.026) and total QoL (p=0.005) were lower after the donation procedure (Noma, 
Hayashi, Uehara, Uemoto, & Murai, 2011). LLDs also reported fewer anxiety symptoms 
following transplantation (Noma, et al., 2011). The study identified social support as a predictor 
of QoL following donation. Those living donors with less familial support had a greater chance 
of worse psychosocial outcome following organ donation. Knowing predictors of these outcomes 
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could allowed clinicians to target this patient population to prevent a negative experience 
following donation. 
 In a long-term study, Ladner, Dew, Forney, Gillespie, Brown, Merion, Freise, Hayashi, 
Hong, Ashworth, Berg, Burton, Shaked, & Butt (2015) followed LLDs for up to 11 years 
following transplant. The best predictor of a negative score on the SF-36 was if the recipient had 
died within 2 years of receiving the kidney transplant (Ladner et al., 2015). One factor that was 
identified as a protective factor was education. LLDs that had a bachelor’s degree generally 
reported a higher PCS score on the SF-36 (Ladner et al., 2015). Even though most LLDs have a 
positive experience following organ donation, and higher education was identified as a 
significant to improved quality of life following organ donation.  This can assist clinicians with 
determining which LLDs need further education and reinforcement of the psychosocial 
expectations following donation to lessen the chance of adversely affecting the LLD’s HRQoL.  
 A long-term cohort study was conducted to evaluate the prevalence of adverse 
psychosocial outcomes in LLDs (Dew, Butt, Liu, Simpson, Zee, Ladner, Holtzman, Smith, 
Pomfret, Merion, Gillespie, Sherker, Fisher, Olthoff, Burton, Terrault, Fox, & DiMartini, 2018). 
The authors in this study found that LLDs were more likely to have anxiety and alcohol abuse 
disorder (Dew et al., 2018). Other factors, such as length of hospital stay, female gender, higher 
body mass index (BMI), fear of health related effects, and out-of-pocket expenses were 
associated with a worse QoL (Dew et al., 2018). Anxiety and substance abuse disorders can have 
a negative impact on the QoL that a LLD has. Screening prior to organ donation for individuals 
at risk of developing substance abuse problems in a LLD population would be beneficial. 
 Previously, Dew, DiMartini, Ladner, Simpson, Pomfret, Gillespie, Merion, Zee, Smith, 
Holtzman, Sherker, Weinrieb, Fisher, Emond, Freise, Burton, and Butt (2016) found several 
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factors that led to lower HRQoL. These factors included male gender (p<0.001) and being non-
Hispanic white (p<0.001) (Dew et al., 2016). The authors also identified a factor that had a 
positive effect on HRQoL, which was being between 40 to 50 years old (p=0.008) (Dew et al., 
2016). Additionally, the MCS scores were poorer in those donors that had extended 
hospitalizations following donation (p=0.009) indicating a decrease in the HRQoL (Dew et al., 
2016). While age can be a protective factor, other predictive factors such as financial costs, 
extended hospitalization, race, and gender might be used to identify donors that require follow-
up care and long-term surveillance.   
 Kimura, Onishi, Sunada, Kishi, Suzuki, Tsuboi, Yamaguchi, Imai, Kamei, Fujisiro, 
Okada, Ishigami, Kiuchi, & Ozaki (2015) evaluated the impact psychiatric conditions had on 
LLDs. The authors identified 6 individuals who had not had a psychiatric issue before donation 
and subsequently developed a psychiatric disorder following organ donation. The 6 individuals 
represent 4.2% of the total number of LLDs (n=142) screened for participation in the study 
(Kimura et al., 2015). The LLDs with a mental health disorder and were treated for the disorders, 
were evaluated before and after the organ donation process. Half of the LLDs were able to stop 
drug therapy during the donation process while the other half required therapy over an extended 
time frame (Kimura et al., 2015). The low prevalence of mental health disorders in individuals 
that donate organs can make it difficult to draw conclusions from a small cohort of living organ 
donors. 
The Relationship Between Physiological and Psychosocial Outcomes in LKD 
 There was one study that met the inclusion criteria and addressed both the physiological 
functioning of the kidney following donation and the psychosocial impact of donation. 
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 The long-term effects of kidney donation on the living donor are not well elucidated 
particularly when trying to determine whether physiological functions affect psychosocial 
outcomes. Meyer, Hartmann, Mjøen, & Andersen (2017) attempted to correlate physiologic 
functioning with QoL in LKDs. There were no significant associations that could be drawn 
between clinical variables, such as blood pressure (BP), creatinine, estimated glomerular 
filtration rate (eGFR), hemoglobin, or cholesterol panels, and QoL scores on the SF-36 (Meyer et 
al., 2017). The only correlations that could be discerned were between gender and general 
fatigue (p < 0.05) and between BMI and physical fatigue (p < 0.01) (Meyer et al., 2107). This 
small-scale study failed to really find a correlation between physiological function 10 years 

















 The studies included in this literature review can provide insight into the psychosocial 
effects that organ donation has on the living donor; however, other factors concerning the 
donation process and outcomes in the transplant recipient that may be important in the living 
donor’s experience following donation have yet to be identified. The main factor identified in 
several of the studies was that graft failure and the resultant death of the recipient led to feelings 
of guilt and negatively affected the psychosocial outcomes experienced by the living donors. 
Various studies also identified predictors that indicated whether the living donors experienced 
psychosocial sequelae from donating their organs. 
Psychosocial Outcomes Experienced by Living Donors 
 Most LKDs and LLDs experienced no adverse effects from donating their organs to 
another person. Some living donors even demonstrated higher measures of psychosocial 
functioning after they had donated their organ. There were a number of LKDs that experienced 
mood disturbances following donation of their kidney. Up to 16% of LKDs were found to have 
new-onset mood disturbances following kidney donation (Rodrigue et al., 2017). The studies by 
in large used questionnaire to measure the living donors’ QoL. Several of the studies also 
employed interviews to ascertain the donors’ feelings about the transplant experience.  
 Most of the studies found that living donors had no negative consequences following the 
transplant procedure (Ladner et al., 2015; Maglakelidze et al., 2011; Maple et al., 2017; Meyer et 
al., 2017; Timmermann et al., 2015). There were several groups of people who seemed to have 
more negative psychosocial outcomes in the studies. The first group that had negative 
psychosocial effects form the donation experience had knowledge that the graft they had donated 
was no longer functioning in the recipient (Butt et al., 2017; Meyer et al., 2016). The other group 
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that tended to have a more negative QoL following donation were those that had pre-existing 
deficits in psychosocial functioning (Hsieh et al., 2017; Rodrigue et al., 2017; Timmerman et al., 
2016). Several studies tried to identify predictors to determine which living donors were most at 
risk of having negative psychosocial outcomes. 
Predictors of Psychosocial Responses Following Donation 
 The psychosocial factors identified in the studies synthesized for this literature review 
were associated with either positive or negative effects on the organ donation outcomes 
experienced by the living donor. There were no uniform predictors of psychosocial response to 
organ donation that could be identified. In several studies gender was predictive of QoL 
measures of psychosocial outcome, such as fatigue (Dew et al., 2016; Hsieh et al., 2017; Meyer 
et al., 2016; Meyer et al., 2017). Another predictor that was identified in some studies was age. 
Being older at the time of organ donation was considered protective and older individuals 
responded more favorable on QoL measures of psychosocial outcomes (Jowsey et al., 2014; 
Rodrigue et al, 2017). The existence of pre-existing mood or mental disorder was found to be a 
negative indicator of psychosocial outcome in living donors (Holscher et al., 2018; Rodrigue et 
al., 2017). The death of the recipient was also a negative indicator to the living donors transplant 
experience (Butt et al., 2017; Jacobs et al., 2015; Rodrigue et al., 2017). 
Barriers to Care of Living Organ Donors 
 Most of the studies suggested living donors should be monitored to ensure the donors did 
not experience any negative psychosocial effects from the transplantation process. One barrier to 
this involved the way the clinician would measure any changes. While the SF-36 was used in 
many of the studies, there were a variety of questionnaires employed in the studies included in 
this review. Without uniformity in the process of data collection, it is difficult to draw over-
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arching conclusions and assumptions to identify psychosocial complications experienced by 
living organ donors and those in need of interventions following donation of an organ. 
 One other variable to address is when the evaluations for psychosocial complications 
should take place following organ donation. There were a wide variety of time points that were 
used to evaluate the psychosocial well-being of the living donors. Some studies looked at long-
term effects of living organ donation by looking at living donor responses to questionnaires a 
decade or more from the time the procedure occurred (Jacobs et al., 2015; Ladner et al., 2015; 
Meyer et al., 2016; Noma et al., 2011). Other studies followed living donors for a much shorter 
time following the transplantation procedure. These studies might have followed the living 
donors for two or less years (Butt et al., 2017; Dew et al., 2018). Given that a living donor’s 
experiences are not likely to be the same at different time periods following the transplantation 
procedure, it is hard to compare studies that encompass such disparate time frames and apply the 
authors’ findings to the living donor population in general. 
 Financial barriers can also present a problem for living donors. There can be large sums 
of out-of-pocket expenses. Living donors can also experience problems obtaining health 
insurance and life insurance following the procedure. Without gaining an understanding of the 
financial implications of living organ donation, it will be impossible to develop ways to contain 









 The studies included in this literature review had several limitations. Using general 
keyword searches, such as organ transplant, living donor, psychosocial, and physiologic, 
provided numerous articles. When filtering for publication dates and language, the number of 
articles germane to the topic greatly diminished. Only one article was identified that completely 
met the inclusion criteria while looking at physiological data and QoL measures. The search was 
expanded by varying the keywords and expanding the search terms to include different 
permutations of the keywords like organ transplant*. The articles included in this review were 
analyzed after appearing in the keyword search to determine whether they met the inclusion 
criteria. This process is subjective, so some articles may have been overlooked while some may 
have been erroneously included. 
 One of the limitations that became apparent from the studies included in this literature 
review was the sample sizes of the studies. Several of the studies had sample sizes smaller than 
50 individuals (Hsieh et al., 2017; Noma et al., 2011; Trotter et al., 2001; Walter et al., 2003; 
Walter et al., 2002). The sample sizes of these studies make it unlikely that the living donor 
population is diverse enough to apply the findings on the population at large. The largest studies 
were multicenter studies that had 2,455 participants (Jacobs et al., 2015; Jowsey, 2014). Not all 
the studies were made up of diverse populations. Several were conducted at single centers in 
Asian or European countries (Hsieh et al., 2017; Kimura et al., 2015; Maglakelidze et al., 2011; 
Meyer et al., 2017; Meyer et al. 2016; Noma et al., 2011; Walter et al., 2003; Walter et al., 
2002). All the studies were a cohort design but given the nature of the question being researched 
that would be expected.  
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 Retention and attrition rates in longitudinal, cohort studies can influence causal 
correlations that occur in a population. Large attrition rates or low retention rates can skew the 
results obtained. Even in the larger trials the response rate is important to note. Only 2,455 living 
donors participated in the study out of 6,909 who had been contacted after they were found to be 
eligible (a 36% response rate) (Jowsey et al., 2014). The people who ended up participating may 
not be representative of the general population. Rodrigue et al. (2017) reported an 84% response 
rate. The longer the study is designed to continue collecting data, the more likely the attrition rate 
















Recommendations for Living Donor Psychosocial Health 
Future Investigations 
 There was one article identified that discusses an ongoing cohort study that seeks to also 
answer whether the physical function of the LKD’s body is correlated to any psychosocial 
outcomes. The study aims to see if kidney function is associated with changes in QoL 
(Suwelack, Wörmann, Berger, Gerß, Wolters, Vitinius, Burgmer, & the German SoLKiD 
consortium, 2018). The primary outcome will be the association of the eGFR with the QoL 
obtained through the SF-36 in LKDs (Suwelack et al., 2018). The results from this study will add 
to the body of literature that meets the inclusion criteria that was set out for this literature review. 
 Further studies using the similar time frames and similar questionnaires are necessary to 
determine whether the psychosocial alteration observed post-donation are applicable across the 
living donor population. It is hard to compare a study carried out 10 years post-donation to one 
that looks at the living donor’s psychosocial outcome one year following donation. Several of the 
studies used several different questionnaires (Holscher et al., 2018; Maglakelidze et al., 2011; 
Maple et al., 2017). While one questionnaire might not be able to measure every aspect of the 
domains of the psychosocial outcomes, it can be hard to directly compare the data obtained from 
two different questionnaires.       
Interventions 
 The predictors identified from studies are an important step in being able to identify 
where interventions can be strategically employed to improve the living donor’s experience 
following organ donation. These predictors allow the clinician to target those more likely to need 
the intervention. Given the multifaceted dimensions related to psychosocial health, it is likely 
that a variety of interventions will have to be developed. 
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 Since there are not many examples of interventions to address psychosocial functioning 
in living donors, ideas can be generated from other conditions. Dew, Zuckoff, DiMartini, Dabbs, 
McMulty, Fox, Switzer, Humar, & Tan (2012) published a report were they had developed an 
intervention and did some feasibility testing to try to prevent negative psychosocial outcomes in 
living donors. The framework the authors used was based upon interventions for motivational 
interviews (MI’s). The goal was to motivate the living donor to change behavior thus improving 
their psychosocial outcome (Dew et al., 2012). While there was no data obtained that directly 
indicated the intervention improved psychosocial outcomes, the authors found that the living 
donors liked being able to talk and have their comments listened to so that any concerns could be 
addressed (Dew et al., 2012). Interventions based upon those used in other conditions might be a 
place to begin since there are a dearth of validated examples. 
 Another intervention, internet-based cognitive-behavioral therapy (ICBT), was proposed 
and tested for its feasibility (Wirken, van Middendorp, Hooghof, Bremer, Hopman, van der Pant, 
Hoitsma, Hillbrands, & Eveers, 2018). The authors developed an ICBT intervention for LKDs 
and donor candidates (Wirken et al., 2018). Anxiety and depression were assessed before and 
after the intervention. Wirken et al. (2018) suggested that the intervention improved measures 
such as depression in the eight living and candidate donors in the pilot study. The study was not 
designed to assess effectiveness so whether the intervention works in practice remains to be seen. 
Nursing Practice 
 The findings synthesized in this review can have various implications to the practice of 
nursing. Nurses need to stay abreast of the research to practice effectively. This review 
condenses what is known about the psychosocial effects of donation on living organ donors. To 
be able to make sound clinical judgements, nurses need to know where holes in the current body 
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of knowledge are so that decisions can be based on the evidence. Nurses are also an advocate for 
their patients. Ultimately, nurses want to prevent harm to their patient by advocating on their 
behalf. 
 Psychosocial domains are multifaceted so will require a team approach to identify and 
address. Nurses are at the best position to help coordinate care to maximize the person’s 
psychosocial outcome. Nurses are frequently the first to see that there is a problem due to the 
amount of time that they spend with their patients. Nurses may be involved in the 
implementation of interventions to resolve any psychosocial problems that living donors have. 
Conclusions 
 While most living organ donors have no problems following donation and report no 
negative psychosocial outcomes, there is a subset of living donors that do not have a pleasant 
experience following donation. The nurse may be involved in identifying living donors at most 
risk of having negative psychosocial outcomes through screeners or participating in a team to 
implement interventions to address any problems. The literature indicates that one of the leading 
factors associated with an adverse psychosocial outcome is related to the death of the recipient 
(Butt et al., 2017; Jacobs et al., 2015; Rodrigue et al., 2017). When the recipient dies following 
graft failure, this should be an indicator to follow the living donor more closely and implement 
any necessary interventions to lessen any negative psychosocial impact. Developing 
interventions to address changes in psychosocial functioning is vitally important. The examples 
found so far are feasibility studies, which while they are a necessary first step. These studies not 
sufficient to address the problem. Effectively identifying which patients are at risk for 
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Figure 1: Method for Literature Review Selection  
 
 
Relevant citations obtained after screening of databases 
(ERIC, CINAHL, PsycINFO, MEDLINE) 
(n=258) 
Citations that do not meet 
inclusion criteria 
(n=201)  
Studies reviewed following retrieval for 
inclusion 
(n=57) 
Studies excluded following retrieval and 
review for not meeting inclusion criteria 
(n=56) 
Studies that met the inclusion criteria 
(n=1) 
Additional studies included following hand searching employing additional keywords 










































Key Findings and Limitations 
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MD was used 
Most LLD scored 
at the midpoint on 
the better person 
scale and the 
PTGI-SF. The 
factors associated 
with affecting the 
better person 
score were time 
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about 4-9.5% of 
the donors had at 
least one of the 
The rate of mental disorders in 
LLD were: 0-3% for major 
depression, 2-5% for alcohol 
abuse, and 2-3% for anxiety 
disorders. One of the factors 
that was identified that is 
associated with a negative 
experience from living liver 
donation is whether the 
recipient dies. The death of the 
recipient has a negative impact 
on the donor. Up to one third of 
those donors felt guilt 
following the death of the 
recipient and up to 22% felt 
some responsibility for the 
death of the recipient. 
 
Limitations: The sample did 
not have a large representation 
of minorities. Also, only 245 
out of the 278 people enrolled 
completed the initial survey 
and one post-donation survey. 
At the two-year post-donation 
only 183 donors were eligible.  
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disorder (p < 
0.001) were more 
common in LLDs. 
Also, the length of 
the hospital stay 
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being female, 
higher BMI, fear 




associated with a 
decrease in QoL.  
Identification of factors 
adversely effecting LLDs is an 
important step forward in 
ensuring that the donation 
process is safe for the donors. 
The researches found that 
anxiety and alcohol abuse 
disorder were seen with an 
increased frequency in LLDs.  
 
Limitations: Some of the 
centers included in this study 
so they have relatively small 
sample sizes coming form that 
site. This could make it hard to 
see differences in those centers.  
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were identified in 
the study that led 
to a lower HRQoL 
which include 
male gender (OR 
6.23, p < 0.001) 
The study found that LLD 
report adverse physical and 
socioeconomic effects from 
donation. Those at greatest risk 
are non-Hispanic white males. 
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(OR 6.35, p < 
0.001). Age 40 to 
50 years old (OR 
0.26, p=0.008) 
were more likely 
to have favorable 
psychological 





donation.   
having physical or financial 
concerns following donation. 
 
Limitations: The study is cross-
sectional, which prevents 
comparing pre- and post-
donation status. The study was 
conducted in adults so whether 
the findings correlate to the 
pediatric population experience 
is impossible to infer. 



































April 2000 and 
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The results from 
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for the LLD was 
56.4 versus 50.5 
(p < 0.001). 
However, the 
mental composite 
score was not 
statistically 
different than the 
average Canadian 
score. Physical 
functioning (p < 
In the SF-36v1 the LLDs 
scored better than the average 
Canadian on the physical 
domains, but no predictors of 
HRQoL post-donation could be 
determined. On the other hand, 
there were several predictors 
that could be identified for the 
mental HRQoL post-donation. 
Age (p=0.023), presence of a 
psychiatric diagnosis 
(p=0.007), degree attained 
(p=0.001), and pre-donation 
concerns about donation all 
(p=0.029) were all predictors of 
mental health changes seen 
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interference (p < 
0.05), bodily pain 
(p < 0.001), 
general health (p < 
0.001), and 
vitality (p < 0.05) 
were all domains 
that the LLDs 
scored better than 
the average 
Canadian on.  
Limitations: The response rate 
for this study was 70%, so a 
large portion of eligible 
participants were either lost to 
follow-up or chose not to 
participate. This can affect the 
study’s validity because the 
population might not be 
representative of all the people 
that undergo this procedure. 
The study did not give the 
questionnaires to the 
participants at set timepoints. 
The LLDs feelings of the 
experience could change over 
time so comparing different 
donors at different time points 
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included a score 
of 3 or higher on 
the GAD-2 
anxiety screen, a 
score of 3 or 
higher on the 
PHQ-2 depression 
screen, and the 5-
point Likert scale.  
A positive screen 
for depression was 
more likely if the 
person also 
Overall the incidence of 
anxiety, depression, and 
regretting the decision to 
donate their liver occurred in 
5.5%, 4.2%, and 2.1% of the 
respondents. These conditions 
were very inter-related and a 
positive screen for one was 
often correlated with a positive 
screen for another.  
 
Limitations: Unlike other 
studies, this study was 
conducted at one transplant 






for anxiety (p < 
0.001). A positive 
depression screen 
was also more 
likely to occur 
when the recipient 
experienced graft 
loss (p < 0.001). 
In addition, regret 
was more likely to 
be seen when the 




potential pool or participants. 
The study may not have 
enough participants to truly be 
able to see differences between 
the outcomes and donor 
characteristics. 








of the study is 
to determine 
the factors 







n=41 The physical 




















more than 3 
months before 
participating in 
the study. All 
participants had 

























When the LKD had a higher 
positive affect, their HRQoL 
scores were generally higher (p 
< 0.05). Employment led to 
higher mental HRQoL (p < 
0.05). When LKD had a lower 
negative affect score, their 
mental HRQoL was higher (p < 
0.01). Men, donors who are 
siblings of the recipient, donors 
having chronic disease, and 
having poor physical health 
were more likely to have a 
decreased HRQoL.  
 
Limitations: This study was 


























affect than men (p 
< 0.05). Lack of a 
chronic disease 
was associated 
with a positive 
affect (p < 0.05). 





score was higher 
(p < 0.01). 
exclusively Asian participants, 
which limits wider application 
of its findings. 



































to 2012 with 
LKD that 
donated from 
June 1963 to 
June 2005. The 
mean time 
In regard to 
psychosocial 
outcomes, the 




due to donation; 





or regrets with 
donating their 
kidney. The only 
A total of 231 patients reported 
that they experienced a 
negative psychosocial outcome 
following donation. Almost 1 
in 10 donors experienced a 
negative consequence related to 
their decision to donate their 
kidney. One in 5 donors ended 
up taking unpaid leave and up 
to 2% reported having concerns 
with life and health insurance, 
which contributes to the 





was 17 years 
(ranged from 5 




had a 4-year 
college degree) 
and were white 
(93%).   
predictor that was 
associated with 
poor psychosocial 
outcome was that 
the recipient’s 
kidney was no 
longer functioning 
(OR 1.77, CI 
1.33-2.34, p < 
0.001). 
Limitations: While this study 
had a larger sample size, the 
response rate was only 36%.  








of this study 
was to reveal 
the long-term 
effects of 














to the study. 
The donors 
were then 
invited to join 


















and 2005 at one 
of 3 transplant 
centers. Areas 
queried in the 
questionnaire 











The study utilized 







and the 36-Item 
Short Form Health 
Survey (SF-36) 
for measuring 




associated in LKD 
who reported 
better physical 
health (p < 0.001), 
older when 
underwent 
For the most part LKD do not 
experience an increase in 
depressive symptoms. The 
minority that do experience 
depressive symptoms have a 
history of depression that 
predates kidney donation. 
Longer recovery (p=0.009), 
financial stressors (p=0.013), 
younger (p=0.002), obligation 
to donate (p=0.003), and 
recipient graft status (p=0.007) 
are associated with a LKD 
more likely to develop 
depression.  
 
Limitations: While the study 
included patients from three 
transplant centers, there was 
less representation of ethnic 
minorities than represented in 













higher score on 
the LOT-R (p 
<0.001), being 
employed (p < 
0.001), and being 
white (p=0.002)   
















quality of life. 
n=142 The potential 
donors were 

























this study were 
selected 
between April 
2004 and July 
2005. The 
subjects 
included in this 
study did not 















Six (4.2%) of the 
142 LLDs 
included in this 













and bile leakage. 
All the donors 




their GAF scale 
scores. With 
therapy 3 
This study was very small in 
scale. Essentially only 6 LLDs 
were identified as having a 
mental health disorder out of 
the 142 screened. In half the 
LLDs that developed a mental 
disorder therapy was required 
over an extended period of 
time. The exact cause of the 
mental disorders is not entirely 
clear. It could be due many 
factors including relationship 
problems with the recipient, 
death of the recipient following 
transplant, and environmental 
and genetic factors. 
 
Limitations: The sample size in 
this study is small. Only 6 
people out of the 142 total LLD 
identified as having a mental 
health disorder and followed 
through the course of their 
mental illness. This study was 














Scale (GAF).   
achieved 
remission while 3 
continued 
treatment.  
transplant center in Japan, so 
whether the results would hold 
up nation-wide or in other 
countries has not been 
addressed.     





The goal for 
this study is to 
characterize 
the HRQoL 














at 3 months, 
one year, and 
then yearly up 
to 8 years 
post-donation. 
Between 2004 
and 2013, LLD 
were evaluated 
with the Short 
Form survey 
(SF-36) for 
LLD who had 
donated 
between 1998 
and 2010. The 
researchers 





(PCS and MCS, 
respectively).  
The SF-36 
consists of 36 
questions that 
provides data to 
compute the PCS 
and MCS scores. 
The average age at 
donation was 38 
and 93% of the 
donors were 
white. 43% of the 
donors had a 
bachelor’s degree 
or higher. The 
largest predictor 
of a poor PCS or 
MCS score was 
the death of the 




MCS p=0.0004).  
While most LLD maintain their 
HRQoL post donation, there 
are a subset of LLD that are not 
able to maintain these levels 
and develop a poor HRQoL. 
Educational level is a 
protective factor in those with a 
bachelor’s degree or higher 
generally reporting a higher 
PCS score (p=0.023).    
 
Limitations: This study was 
generated from several 
transplant centers; however, 
93% of the participants were 
white, which does not reflect 
















a sample of 
healthy 
matched 





















The mean age 
of the LKD 
included in the 
study was 49 
years old. 
There had been 
61 kidney 
transplants 
since 2005 and 





This gives a 
93% response 









to patients who 
had 
nephrectomies 
due to renal 
tumors. This is 
a novel 
approach and 
allows them to 
The SF-36 found 
three domains 
where the LKD 
were seen to 
function 
statistically 







three domains that 
the LKD scored 
higher than the 
control group. In 
the GBB-24, the 
LKD group scored 
higher than the 
other groups but 




than the control’s 
scores. The mood 
of the LKD were 
also significantly 
better than the 
controls 
(p=0.0007). 
This study found that the 
HRQoL was generally better 
for LKD. There were not any 
dimensions that the authors 
mentioned where either the 
controls or renal tumor patients 
out-scored the LKD.  
 
Limitations: The sample size is 
small and relatively 
homogenous given the 
countries size. It would be hard 
to extrapolate these findings 
























n=77 LKD were 
recruited for 





















The LKD were 
selected for this 
study between 























At 3 months, LKD 
scored lower on 
physical HRQoL 
(p < 0.05) 
compared to their 
pre-operative 
scores. While 
there was a 
general increase in 







From this LKD 
population, 6.8% 
regretted their 
decision to donate 
at 3-months, and 
10.7% regretted 
their decision at 
12-months.    
Overall, there was very little 
change in the overall 
psychosocial health of LKD in 
this study. The second part of 
the study reflected the feelings 
LKD had regarding the 
process. Most LKD had 
positive feelings about 
donating their kidneys. The 
authors purported no benefit 
from kidney donation for the 
living donor, but there was not 
a negative effect either.  
 
Limitations: This study had a 
relatively small sample size. 
Given that questions were 
added that were not part of 
validated questionnaires, the 
changes seen over time might 






















or a reduction 
in HRQoL in 
living donors. 





































HDL and LDL. 
Scores from the 
PCS and MCS 
were obtained 
from the SF-
36v2.   






and either the PCS 






general fatigue (p 
< 0.05) and 
between BMI and 
physical fatigue (p 
< 0.01).    
This was one of the initial 
studies that looked to see if 
there was a correlation with the 
donors physiological state with 
the psychosocial outcomes a 
decade after donation. 
Hypertension may be more 
prevalent in the LKD group, 
but it does not achieve 
statistical significance.  
Limitations: The study may not 
have been powered to detect 
differences due to the size of 
the effects measured and the 
population included in the 
study. The study also took 
place in Norway, which is not 
as diverse as other places such 
as the US, so the authors’ 
conclusions might not have 
generalizability.  








of this study 
was to follow 
a cohort of 
kidney donors 
over 8-12 
























difference in score 
related to age of 
gender. The 
exceptions were 
that females score 
significantly lower 
Most LKD participants in the 
study rated the HRQoL 
favorably. The most important 
implication of this study was 
the gender differences seen in 
the responses to the MFI 
questionnaire. This study 
demonstrated that women rated 
their fatigue higher than men 
within the cohort. This result is 
48 
 
years and see 
if there was 




























on their role 
physical and role 
emotional scores. 
In relation to the 
fatigue score, once 





When looking at 
gender, women 









not consistent with results seen 
in other studies. Further studies 
are necessary to see whether 
this result is significant. 
 
Limitations: This study was 
conducted at one center in 
Norway. Also, the population 
is less diverse in this country 
than in other such as the US. 
The findings may not be 
applicable to the across all 
countries and ethnicities due to 
the homogeneity of the 
Norwegian population. 













The goal was 





































The main predictors of the 
donor’s psychosocial state 
following liver transplant were 
family or support system 
availability and the recipients’ 
depressive states when the liver 
transplant is performed. The 
social QoL was affected in both 
donors and recipients 3 to 5 



























by looking at 












Limitations: This study only 
included 30 donors and 40 
recipients. This study is also 
conducted exclusively in Japan 
and the results might not be 
applicable in other countries or 









of this study 























and anger. To 



























or Spanish. For 
assessing mood 







showed that both 
LKDs and HCs 
scored similarly 
on most of the 
HRQoL measures. 
Older age is 






associated with a 
higher mood 
disturbance score 
(p=0.01). Fear of 
kidney failure is 
associated with 
pre-donation 
For the most part, the incidence 
of new onset mood 
disturbances, body image 
issues, life dissatisfaction, and 
fear of kidney failure were low 
in this study. The reported 
incidences were 16%, 13%, 
10%, and 21%, respectively. 
These values are in agreement 
with what other researchers had 
published, but further studies 
are necessary to ensure that 
there really is a difference 
between LKDs and HCs.  
 
Limitations: Only 20 HCs were 
included in the analysis of this 
study. That is not a large 
enough number to truly 
compare the two groups. The 




mood, fear of 
kidney failure, 

































kidney failure (p < 
0.001) and 
associated with a 






















associated with a 
higher score (p < 
0.001). 
and unlikely to truly reflect the 
population as a whole. 
Timmerman 







of this study 
n=151 The 
participants 








Mental health was 
measured by the 
Brief Summary 
Intervention (BSI) 
and the Positive 
Being young and a deficiency 
in social support were 
associated with an increase in 
psychological symptoms 















at 3 and 12 
months.   
2012. LKDs 
had to be at 
least 18 years 
















scored using the 
COPE-Easy.   
respectively). More stress led 
to a decrease in overall well-
being (p <0.001). 
 
Limitations: Some of the scales 
used to quantify the 
questionnaires have not had 
their validity confirmed in the 
situation. The sample size is 
relatively small which can 




































Mental health was 
assessed utilizing 
the BSI and 
MHC-SF. There 





The analysis of the study fails 
to provide evidence that the 
HRQoL is affected by any of 
the factors identified in this 
study. 
 
Limitations: The patients in the 
LKD group are more likely to 
be older, which may not reflect 
the normal age distribution. 











In August of 




similarly to the 
HCs in all 
domains of the 
Major and minor complications 
occurred in 16% of the donors. 
Most LLD made a complete 











36) to assess 
the 
psychosocial 




sent the SF-36 
questionnaire. 
The LLDs 
mean age was 
33.2 years old. 
Men also made 
up 58% of the 
cohort.  
SF-36 except for 
physical function, 
social function, 
and mental health 
(p < 0.05) where 
the LLDs scores 
were higher than 
the controls. 
approximately 3.4 months to 
achieve. Even though the 
procedure was not painless and 
there was a significant out-of-
pocket expense associated with 
donating their liver, all donors 
answered that they would 
donate again. 
 
Limitations: This study has a 
small sample size and the racial 
make-up of the study does not 
reflect the racial make-up of 
the US population. 71% of the 
participants were white in this 
study.  






of this study 






















The LLDs were 
recruited 
between 
August 2000 to 
January 2002. 
The average 
age of the LLD 
was 41 years 
old. The 
domains 









members of the 
cohort scored 
significantly better 
than the controls 
in all domains 
measured with the 
WHOQOL 
questionnaire (p < 
0.05). Once the 
donors made it to 
the 6-month mark, 
they scored lower 
on physical health 
(p < 0.05) and 
In general, most of the LLDs 
reported that their QoL as 
good. This study served as an 
early example on which others 
have expanded our 
understanding of the HRQoL. 
The majority of donors in this 
study were not affected by the 
procedure; however, to really 
determine whether there is an 
effect there needs to be a larger 
sample size.  
 
Limitations: This study is small 
and was included to provide 







(p < 0.05). 





The goal of 













































was 41 years 
old (ranged 
from 20-years 
old to 66 years 
old). Donors 
were assessed 
using a variety 






due to lack of 
German 
proficiency. 






Global quality of 
life significantly 






donation 26% had 
high values for 
tiredness (p < 
0.0012) and 






different from the 
average 
population. 
Generally, LDLT donors rated 
their global QoL higher 
following donation of their 
liver. While donors reported 
increases in tiredness (p < 
0.021) and fatigue (p < 0.0012) 
6 months following organ 
donation (p < 0.021), donors 
reported less anxious 
depression following donation 
(p < 0.002). Post-operative 
complications did not 







Limitations: The sample size 
for this study is extremely 
small. Also, the donors were 
usually spouses or children of 
the recipients, which could 
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